Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma. [electronic resource]
- Mediators of inflammation 2010
- 567351 p. digital
Publication Type: Journal Article; Review
1466-1861
10.1155/2010/567351 doi
Animals Antibodies, Neutralizing--therapeutic use Asthma--immunology Humans Protein Isoforms--antagonists & inhibitors Receptors, Interleukin-1--antagonists & inhibitors Signal Transduction--immunology